{"id":"W2063484906","doi":"10.1016/j.ahj.2013.06.024","title":"Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Ivabradine; Medicine; Ejection fraction; Cardiology; Internal medicine; Coronary artery disease; Myocardial infarction; Placebo; Clinical endpoint; Heart failure; Heart rate; Randomized controlled trial; Angina; Sinus rhythm; Atrial fibrillation; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047679,0.006185596,0.005844126,0.002140296,0.003408039,0.003671124,0.003383999,0.006053395,0.01700185],"category_scores_gemma":[0.03138521,0.00423206,0.004063191,0.001584253,0.006502908,0.002141967,0.001356742,0.007498324,0.005326255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002386342,"about_ca_system_score_gemma":0.01014187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001411179,"about_ca_topic_score_gemma":0.002310124,"domain_scores_codex":[0.978795,0.01256593,0.002289097,0.002591251,0.002375495,0.001383277],"domain_scores_gemma":[0.9910092,0.002533764,0.001708929,0.001077953,0.001518802,0.002151272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7317774,0.01862989,0.02129441,0.02538918,0.005219044,0.001715297,0.001544002,0.003878986,0.01138722,0.0408823,0.03222368,0.1060586],"study_design_scores_gemma":[0.7573932,0.0598917,0.02994537,0.006520282,0.008223534,0.001364509,0.0004809976,0.00458753,0.003838492,0.02256732,0.1046618,0.0005252974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.05339111,0.01608665,0.02412048,0.00980287,0.007389129,0.870133,0.009470607,0.0003308596,0.009275281],"genre_scores_gemma":[0.08711477,0.003755518,0.03414924,0.009586181,0.002245158,0.8563653,0.002653351,0.00006287574,0.004067562],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.047679,"threshold_uncertainty_score":0.2521537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0334377542041952,"score_gpt":0.3131898249119581,"score_spread":0.2797520707077629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}